Anticoagulation therapy for the prevention of stroke and systemic embolism in atrial fibrillation.
Anticoagulation Europe (UK)
Atrial Fibrillation Association
British Cardiovascular Society
British Heart Foundation
European Society of Cardiology
Northern Ireland Chest, Heart and Stroke Association
NICE (CG180) Atrial fibrillation: the management of atrial fibrillation
NICE (CG180) Atrial fibrillation: the management of atrial fibrillation – tools and resources
NICE (CG180) Atrial fibrillation: patient decision aid
NICE (TA355) Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation
NICE (TA249) Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation
NICE (TA256) Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation
NICE (TA275) Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation
NICE (CG162) Stroke rehabilitation: Long-term rehabilitation after stroke
Last updated on 25th July 2016, Version 1.1.0.
Developed as part of a joint working group initiative comprising the National Institute for Health and Care Excellence (NICE), Boehringer Ingelheim Ltd and Prescribing Decision Support Ltd at the Centre for Medicines Optimisation, Keele University.
Keele University and PDS Ltd reserves the right to update and change the Tool at any time in order to address changes in NICE clinical guidance and respective drug SPCs, improve functionality and reflect changing user and business needs. Keele University / PDS Ltd also reserves the right to withdraw the Tool if and when its content is out of date and no longer consistent with NICE clinical guidance.
© 2016 Keele University
© 2016 Prescribing Decision Support Ltd